BB's Stock Haven

[fahrenheitjules]

$LAHO DD - R/M binding LOI Signed for Lans Holdings to acquire Global Stem Cells Group (GSCG)!

Reverse Merger DD satisfaction statement & asset acquisition agreement expected before end of July!

Comprehensive LAHO DD - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149600664

GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.

Adimarket Releases New Exosomes Product that Delivers Therapeutic Promise

http://www.stemcellsgroup.com/adimarket-releases-new-exosomes-product/

ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center

http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/

Benito Novas, Global Stem Cells Group CEO Announces Opening of New Stem Cell Center in Valencia, Spain

http://www.stemcellsgroup.com/benito-novas-gscg-ceo-announces-new-stem-cell-center-in-valencia-spain/

Excerpt from GSCG’s Story:

“Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients. We focus specifically on stem cell research as a source of potential treatments for a wide range of conditions and diseases—in fact, we strongly believe that stem cell and regenerative medicine protocols are the future of modern medicine. GSCG works closely with patients, educators, physicians, regulators and policy makers to foster engagement and develop materials that promote stem cell technology.

As a worldwide network, Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards. The combined efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions.”